首页> 外文期刊>Toxicon: An International Journal Devoted to the Exchange of Knowledge on the Poisons Derived from Animals, Plants and Microorganisms >Characterization of a fibrinogen-clotting enzyme from Trimeresurus stejnegeri venom, and comparative study with other venom proteases
【24h】

Characterization of a fibrinogen-clotting enzyme from Trimeresurus stejnegeri venom, and comparative study with other venom proteases

机译:源自Trimeresurus stejnegeri毒液的纤维蛋白原凝结酶的表征,以及与其他毒液蛋白酶的比较研究

获取原文
获取原文并翻译 | 示例
           

摘要

Trimeresurus stejnegeri venom, which contains TSV-PA (a specific plasminogen activator sharing 60-70% sequence homology with venom fibrinogen-clotting enzymes), also possesses fibrinogen-clotting activity in vitro. A fibrinogen-clotting enzyme (stejnobin) has been purified to homogeneity by gel filtration and ion-exchange chromatography on a Mono-Q column. It is a single-chain glycoprotein with a mol. wt of 44,000. The NH2-terminal amino acid sequence of stejnobin shows great homology with venom fibrinogen-clotting enzymes and TSV-PA. Like TSV-PA, stejnobin was able to hydrolyse several chromogenic substrates. Comparative study of substrate specificities of stejnobin and other venom proteases purified in our laboratory was carried out on five chromogenic substrates. Stejnobin clotted human fibrinogen with a specific activity of 122 NIH thrombin-equivalent units/mg protein. However, stejnobin did not act on other blood coagulation factors, such as factor X, prothrombin and plasminogen. Diisopropyl fluorophosphate and phenylmethanesulfonyl fluoride inhibited its activity, whereas ethylenediamine tetracetic acid had no effect on it, indicating that it is a serine protease. Although stejnobin showed strong immunological cross-reaction with polyclonal antibodies raised against TSV-PA, it was interesting to observe that, unlike the case of TSV-PA, these antibodies did not inhibit the amidolytic and fibrinogen-clotting activities of stejnobin. (C) 1998 Elsevier Science Ltd. All rights reserved. [References: 25]
机译:含有TSV-PA(一种特定的纤溶酶原激活物,与毒液中的纤维蛋白原凝固酶具有60-70%的序列同源性)的Trimeresurus stejnegeri毒液在体外也具有纤维蛋白原的凝固活性。已通过凝胶过滤和离子交换色谱在Mono-Q柱上将血纤维蛋白原凝结酶(stejnobin)纯化至均质。它是具有摩尔的单链糖蛋白。重量为44,000。甜菊糖素的NH2末端氨基酸序列与毒液纤维蛋白原凝结酶和TSV-PA具有高度同源性。像TSV-PA一样,甜菊糖能够水解多种生色底物。在五种生色底物上进行了在我们实验室中纯化的甜菊糖蛋白和其他毒蛋白酶的底物特异性的比较研究。 Stejnobin凝结的人纤维蛋白原具有122 NIH凝血酶当量单位/ mg蛋白的比活性。但是,stejnobin不会作用于其他凝血因子,例如X因子,凝血酶原和纤溶酶原。氟磷酸二异丙酯和苯基甲磺酰氟抑制了它的活性,而乙二胺四乙酸对它没有作用,表明它是一种丝氨酸蛋白酶。尽管甜菊糖蛋白与针对TSV-PA的多克隆抗体表现出强烈的免疫交叉反应,但有趣的是,与TSV-PA的情况不同,这些抗体没有抑制甜菊糖蛋白的酰胺分解和纤维蛋白原凝结活性。 (C)1998 Elsevier ScienceLtd。保留所有权利。 [参考:25]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号